ArcaScience, the world leader for AI drugs' Benefit-Risk prediction
ArcaScience has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
ArcaScience's investors include Plug and Play, Bpifrance, Akka, The Moon Venture, Pleiade Venture.
ArcaScience is headquartered in Paris, France.
ArcaScience, the world leader for AI drugs' Benefit-Risk prediction
ArcaScience is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ArcaScience — Funding & Investors." VCBacked, June 12, 2025, https://www.vcbacked.co/company/arcascience. Accessed July 30, 2026.
VCBacked. (2025). ArcaScience — Funding & Investors. Retrieved July 30, 2026, from https://www.vcbacked.co/company/arcascience
{{cite web |title=ArcaScience — Funding & Investors |url=https://www.vcbacked.co/company/arcascience |website=VCBacked |access-date=July 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated